Valeant Pharmaceuticals International, Inc. (VRX) At $17.18 Forms Top; Profile of 1 Analysts Covering Grupo Aeroportuario del Sureste, S. A. B. de C. V. (ASR)

December 7, 2017 - By wolcottdaily

Valeant Pharmaceuticals International, Inc. (VRX) formed multiple top with $17.70 target or 3.00% above today’s $17.18 share price. Valeant Pharmaceuticals International, Inc. (VRX) has $5.99 billion valuation. The stock increased 1.97% or $0.3323 during the last trading session, reaching $17.1823. About 2.38 million shares traded. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has declined 48.51% since December 7, 2016 and is downtrending. It has underperformed by 65.21% the S&P500.

Among 4 analysts covering Grupo Aeroportuario del Sureste (NYSE:ASR), 1 have Buy rating, 1 Sell and 2 Hold. Therefore 25% are positive. Grupo Aeroportuario del Sureste had 6 analyst reports since August 25, 2015 according to SRatingsIntel. The rating was downgraded by Bank of America to “Neutral” on Wednesday, November 9. The stock has “Buy” rating by Goldman Sachs on Friday, January 22. The firm has “Equal-Weight” rating given on Tuesday, May 30 by Morgan Stanley. The company was downgraded on Monday, May 15 by JP Morgan. See Grupo Aeroportuario del Sureste, S. A. B. de C. V. (NYSE:ASR) latest ratings:

Grupo Aeroportuario del Sureste, S. A. The company has market cap of $5.66 billion. B. de C. It has a 21.7 P/E ratio. V. holds concessions to operate, maintain, and develop airports in the southeast region of Mexico.

The stock decreased 0.74% or $1.3 during the last trading session, reaching $174.28. About 297 shares traded. Grupo Aeroportuario del Sureste, S. A. B. de C. V. (NYSE:ASR) has risen 25.40% since December 7, 2016 and is uptrending. It has outperformed by 8.70% the S&P500.

Investors sentiment decreased to 1.08 in Q2 2017. Its down 0.16, from 1.24 in 2017Q1. It dropped, as 53 investors sold Valeant Pharmaceuticals International, Inc. shares while 76 reduced holdings. 49 funds opened positions while 90 raised stakes. 171.89 million shares or 1.47% more from 169.41 million shares in 2017Q1 were reported. Raymond James Serv Advisors owns 76,792 shares for 0.01% of their portfolio. First Allied Advisory Svcs reported 16,465 shares or 0.01% of all its holdings. 28,631 were accumulated by Penn Management Inc. Balyasny Asset Mngmt Lc holds 0.01% or 175,534 shares. M&R Cap Mgmt holds 200 shares. New York-based Blackrock Incorporated has invested 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Prudential Public Limited Com accumulated 279,861 shares. Moreover, Blair William & Il has 0.01% invested in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) for 72,866 shares. Janney Montgomery Scott has 0% invested in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Columbus Hill Management L P owns 968,221 shares or 1.68% of their US portfolio. State Of New Jersey Common Pension Fund D, a New Jersey-based fund reported 20,000 shares. Credit Agricole S A reported 36,156 shares. Ipg Inv Lc reported 11,750 shares. Ftb Advisors Inc owns 3,000 shares. D E Shaw & Inc accumulated 0.01% or 363,271 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 wolcottdaily




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: